Laboratory Issuance Of Capital Stock vs Depreciation Analysis
LH Stock | USD 242.15 3.42 1.43% |
Laboratory financial indicator trend analysis is infinitely more than just investigating Laboratory recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Laboratory is a good investment. Please check the relationship between Laboratory Issuance Of Capital Stock and its Depreciation accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Issuance Of Capital Stock vs Depreciation
Issuance Of Capital Stock vs Depreciation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Laboratory Issuance Of Capital Stock account and Depreciation. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Laboratory's Issuance Of Capital Stock and Depreciation is -0.67. Overlapping area represents the amount of variation of Issuance Of Capital Stock that can explain the historical movement of Depreciation in the same time period over historical financial statements of Laboratory of, assuming nothing else is changed. The correlation between historical values of Laboratory's Issuance Of Capital Stock and Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Issuance Of Capital Stock of Laboratory of are associated (or correlated) with its Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation has no effect on the direction of Issuance Of Capital Stock i.e., Laboratory's Issuance Of Capital Stock and Depreciation go up and down completely randomly.
Correlation Coefficient | -0.67 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Issuance Of Capital Stock
Depreciation
Depreciation indicates how much of Laboratory value has been used up. For tax purposes Laboratory can deduct the cost of the tangible assets it purchases as business expenses. However, Laboratory of must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Most indicators from Laboratory's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. As of now, Laboratory's Tax Provision is increasing as compared to previous years. The Laboratory's current Enterprise Value is estimated to increase to about 7.8 B, while Selling General Administrative is projected to decrease to under 1.1 B.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 5.6B | 4.4B | 3.4B | 2.0B | Total Revenue | 16.1B | 14.9B | 12.2B | 12.8B |
Laboratory fundamental ratios Correlations
Click cells to compare fundamentals
Laboratory Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Laboratory fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 98.6M | 98M | 97.5M | 91.6M | 87.6M | 96.0M | |
Total Assets | 18.0B | 20.1B | 20.4B | 20.2B | 16.7B | 17.6B | |
Other Current Liab | 942.4M | 784.2M | 967M | 1.6B | 504.3M | 478.7M | |
Total Current Liabilities | 1.9B | 2.6B | 3.1B | 2.8B | 3.2B | 3.4B | |
Total Stockholder Equity | 7.6B | 9.4B | 10.3B | 10.1B | 7.9B | 8.3B | |
Property Plant And Equipment Net | 2.6B | 2.7B | 2.8B | 3.0B | 2.9B | 3.1B | |
Net Debt | 6.7B | 5.4B | 4.9B | 5.9B | 5.4B | 5.7B | |
Retained Earnings | 7.9B | 9.4B | 10.5B | 10.6B | 7.9B | 8.3B | |
Accounts Payable | 632.3M | 638.9M | 621.3M | 852.2M | 827.5M | 868.9M | |
Cash | 337.5M | 1.3B | 1.5B | 430M | 536.8M | 290.8M | |
Non Current Assets Total | 15.0B | 14.9B | 15.1B | 15.5B | 13.0B | 13.6B | |
Non Currrent Assets Other | 435.4M | 410M | 462.6M | 432.7M | 536.5M | 270.8M | |
Cash And Short Term Investments | 337.5M | 1.3B | 1.5B | 430M | 536.8M | 299.7M | |
Net Receivables | 2.0B | 3.0B | 3.0B | 2.0B | 2.1B | 2.2B | |
Liabilities And Stockholders Equity | 18.0B | 20.1B | 20.4B | 20.2B | 16.7B | 17.6B | |
Non Current Liabilities Total | 7.8B | 7.6B | 7.3B | 7.0B | 5.6B | 3.1B | |
Other Current Assets | 373.7M | 364.8M | 478.1M | 2.4B | 655.3M | 688.1M | |
Other Stockholder Equity | 26.8M | 110.3M | (192M) | (493.2M) | 38.4M | 36.5M | |
Total Liab | 10.5B | 10.7B | 10.1B | 10.1B | 8.8B | 9.3B | |
Total Current Assets | 3.0B | 5.1B | 5.3B | 4.6B | 3.8B | 4.0B | |
Short Long Term Debt Total | 7.1B | 6.8B | 6.3B | 6.3B | 6.0B | 3.0B | |
Intangible Assets | 4.0B | 4.0B | 3.7B | 3.9B | 3.3B | 2.0B | |
Short Term Debt | 621.1M | 774.1M | 396.5M | 471.1M | 1.3B | 1.4B | |
Inventory | 244.7M | 423.2M | 401.4M | 470.6M | 474.6M | 498.3M | |
Property Plant And Equipment Gross | 2.6B | 2.7B | 5.2B | 5.7B | 5.8B | 6.1B | |
Accumulated Other Comprehensive Income | (372.4M) | (161.9M) | (192M) | (493.2M) | (59.3M) | (62.3M) | |
Other Liab | 1.3B | 1.4B | 1.2B | 1.1B | 1.2B | 702.7M | |
Other Assets | 356.5M | 350.9M | 484.2M | 440.3M | 506.3M | 531.7M | |
Long Term Debt | 5.8B | 5.4B | 5.4B | 5.0B | 4.1B | 3.1B | |
Property Plant Equipment | 2.7B | 2.8B | 2.8B | 3.0B | 3.4B | 3.6B | |
Good Will | 7.9B | 7.8B | 8.0B | 8.1B | 6.1B | 4.4B | |
Current Deferred Revenue | 451M | 506.5M | 558.5M | 582.1M | 421.7M | 442.8M | |
Net Tangible Assets | (4.3B) | (2.4B) | (1.4B) | (2.0B) | (1.8B) | (1.9B) | |
Long Term Debt Total | 5.9B | 5.5B | 5.5B | 5.1B | 5.9B | 4.8B |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 2.88 | Earnings Share 5.28 | Revenue Per Share 151.028 | Quarterly Revenue Growth 0.074 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.